NKCx Histopathological outcome* within 12 months after cervix cytology in 2021
777 Skåne

  Benign LSIL HSIL AIS Cancer Other PAD missing Total
Cytologi Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel Antal Andel
Benign sample 80 0.7% 12 0.1% 5 0.0% . . . . 3 0.0% 11013 99.1% 11113 100.0%
ASCUS 631 29.3% 285 13.3% 101 4.7% 3 0.1% 1 0.0% 32 1.5% 1097 51.0% 2150 100.0%
LSIL 264 21.3% 293 23.6% 171 13.8% 4 0.3% 1 0.1% 32 2.6% 474 38.3% 1239 100.0%
Atypical glandular cells/AGC 7 31.8% 2 9.1% . . 6 27.3% . . 2 9.1% 5 22.7% 22 100.0%
Unclear atypia 1 33.3% . . . . . . . . . . 2 66.7% 3 100.0%
ASC-H 22 14.8% 26 17.4% 93 62.4% 1 0.7% 1 0.7% 1 0.7% 5 3.4% 149 100.0%
HSIL 13 8.4% 8 5.2% 114 73.5% 6 3.9% 5 3.2% 2 1.3% 7 4.5% 155 100.0%
Suspected Adenocarcinom . . 1 11.1% . . 6 66.7% 2 22.2% . . . . 9 100.0%
Totalt 1018 6.9% 627 4.2% 484 3.3% 26 0.2% 10 0.1% 72 0.5% 12603 84.9% 14840 100.0%

NOTE: Histopathological outcome from T83x taken into account.
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad.

* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead.
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'.
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories.
 

Snomed codes in the category Cancer:
M69760, M80703, M80706, M81403